The Role Of MMPs In Chronic Wound Edema
- Volume 16 - Issue 8 - August 2003
- 16153 reads
- 2 comments
1. Vu TH, Werb Z. “Matrix metalloproteinases: effectors of development and normal physiology.” Genes and Development. Vol. 14, No. 17, pp. 2123-2133, Sep 1, 2000.
2. Cullen B. “Part 2: The Role of Oxidized Regenerated Cellulose/Collagen in Chronic Wound Repair” in Matrix Metalloprotease Modulation and Growth Factor Protection. http://www.podiatrytoday.com/WNDS/matrix/pt.cfm.
3. Stacey, Woosey, Wallace. “The Influence of Micro-Environment And Cell Phenotype On Venous Ulcer Healing.” Abstract. European Tissue Repair Society (ETRS). Annual Conference 2001. http://www.etrs.org/bulletin8_3/page7b.html.
4. Rogers, Jude, Oyibo. “Matrix Metalloproteinase (MMP) And Tissue Inhibitor Of Metalloproteinase (TIMP) Expression In Diabetic And Venous Ulcers.” Abstract. European Tissue Repair Society (ETRS). Annual Conference 2001. http://www.etrs.org/bulletin8_3/page7b.html.
5. Ergul et.al. “Evidence for a matrix metalloproteinase Induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes”. American Diabetes Association, Oct 2002. http://www.heart1.com/news/newsfeed.cfm/1280/1.
6. Renò, et. al “Release and Activation of Matrix Metalloproteinase-9 During In Vitro Mechanical Compression in Hypertrophic Scars”. Arch Dermatol. 2002;138:475-478
7. Cook, et al., J Invest Dermatol 2000; 115: 225–233.
8. Herouy Y, et. al., “Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinase: Implications for venous ulcer formation: J Invest Dermatol 1988; 111:822-27.
9. Abstract and commentary by: Fedor Lurie, MD, PhD. Volume 8, Number 12 www.venousdigest.com December 2001.